Search results
Know Your Risk for Blood Clots Before Taking Birth Control
The Journal Times· 4 days ago(StatePoint) In today’s evolving reproductive health landscape, informed decision making about...
What Does a Nutritionist Do?
Health via Yahoo News· 7 hours agoNutritionist is an umbrella term for health professionals who specialize in nutrition and the human diet. Nutritionists are similar to dietitians, but...
YOUR HEALTH: AI getting hearts back in rhythm
WAFB Baton Rouge· 2 days agoAtrial fibrillation, or AFib, is the most common heart rhythm disorder in the world and impacts more than 6 million Americans right now. Not only does...
US FDA extends review of Ascendis Pharma's hormone disorder therapy
Reuters via AOL· 2 days agoU.S.-listed shares of the company were down 6.6% in late afternoon trading. The health regulator...
Love Dessert but Hate Cuteness? Goth Cakes May Be for You.
New York Times· 16 hours agoNow, she’s baking cakes that are, in her words, “a bit rough,” with icing that’s often black or ...
US FDA extends review of Ascendis Pharma's hormone disorder therapy
Reuters· 2 days ago, opens new tab therapy to treat adult patients with a hormone disorder by three months, the company...
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 39 minutes agoHONG KONG, SHANGHAI and FLORHAM PARK, N.J., May 17, 2024 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13) today announces that topline and subgroup results from the ESLIM-01 Phase III study of sovleplenib,
Do we need a federal gun database for mental illness? One family says yes
WINK TV Southwest Florida· 2 hours agoWhen we mention guns, it often sparks an instant reaction. People who own guns think someone might...
Peter Alexander's sister Rebecca started to lose her sight at 12. It was a sign of a rare disease
TODAY via Yahoo News· 8 hours agoWhen Rebecca Alexander was in college, she was grappling with a recent diagnosis of Usher syndrome,...
UPDATE 2-US FDA extends review of Ascendis Pharma's hormone disorder therapy
Reuters via Yahoo Finance· 2 days agoThe U.S. Food & Drug Administration has extended its review of Ascendis Pharma's therapy to treat adult patients with a hormone disorder by three months, the company said ...
